vs
Side-by-side financial comparison of AerSale Corp (ASLE) and DYNAVAX TECHNOLOGIES CORP (DVAX). Click either name above to swap in a different company.
DYNAVAX TECHNOLOGIES CORP is the larger business by last-quarter revenue ($94.9M vs $90.9M, roughly 1.0× AerSale Corp). DYNAVAX TECHNOLOGIES CORP runs the higher net margin — 28.4% vs 5.9%, a 22.4% gap on every dollar of revenue. On growth, DYNAVAX TECHNOLOGIES CORP posted the faster year-over-year revenue change (17.7% vs -4.0%). DYNAVAX TECHNOLOGIES CORP produced more free cash flow last quarter ($32.6M vs $9.8M). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.
ASLE vs DVAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $94.9M |
| Net Profit | $5.4M | $26.9M |
| Gross Margin | 34.1% | — |
| Operating Margin | 7.8% | 22.4% |
| Net Margin | 5.9% | 28.4% |
| Revenue YoY | -4.0% | 17.7% |
| Net Profit YoY | 99.7% | 53.0% |
| EPS (diluted) | $0.10 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $71.2M | $94.9M | ||
| Q2 25 | $107.4M | $95.4M | ||
| Q1 25 | $65.8M | $68.2M | ||
| Q4 24 | $94.7M | $72.0M | ||
| Q3 24 | $82.7M | $80.6M | ||
| Q2 24 | $77.1M | $73.8M | ||
| Q1 24 | $90.5M | $50.8M |
| Q4 25 | $5.4M | — | ||
| Q3 25 | $-120.0K | $26.9M | ||
| Q2 25 | $8.6M | $18.7M | ||
| Q1 25 | $-5.3M | $-96.1M | ||
| Q4 24 | $2.7M | $7.0M | ||
| Q3 24 | $509.0K | $17.6M | ||
| Q2 24 | $-3.6M | $11.4M | ||
| Q1 24 | $6.3M | $-8.7M |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 30.2% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 7.8% | — | ||
| Q3 25 | 4.0% | 22.4% | ||
| Q2 25 | 11.7% | 15.1% | ||
| Q1 25 | -10.1% | -34.7% | ||
| Q4 24 | 5.2% | -2.3% | ||
| Q3 24 | 2.4% | 12.5% | ||
| Q2 24 | -2.4% | 7.0% | ||
| Q1 24 | 5.2% | -35.0% |
| Q4 25 | 5.9% | — | ||
| Q3 25 | -0.2% | 28.4% | ||
| Q2 25 | 8.0% | 19.6% | ||
| Q1 25 | -8.0% | -141.0% | ||
| Q4 24 | 2.9% | 9.8% | ||
| Q3 24 | 0.6% | 21.8% | ||
| Q2 24 | -4.7% | 15.4% | ||
| Q1 24 | 6.9% | -17.2% |
| Q4 25 | $0.10 | — | ||
| Q3 25 | $0.00 | $0.21 | ||
| Q2 25 | $0.18 | $0.14 | ||
| Q1 25 | $-0.10 | $-0.77 | ||
| Q4 24 | $0.05 | $0.07 | ||
| Q3 24 | $0.01 | $0.12 | ||
| Q2 24 | $-0.07 | $0.08 | ||
| Q1 24 | $0.12 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $160.2M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $534.1M |
| Total Assets | $640.5M | $946.5M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | — | ||
| Q3 25 | $5.3M | $160.2M | ||
| Q2 25 | $5.7M | $99.1M | ||
| Q1 25 | $4.7M | $51.7M | ||
| Q4 24 | $4.7M | $95.9M | ||
| Q3 24 | $9.8M | $119.3M | ||
| Q2 24 | $4.3M | $112.5M | ||
| Q1 24 | $2.6M | $132.0M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | — | ||
| Q3 25 | $417.1M | $534.1M | ||
| Q2 25 | $415.9M | $494.2M | ||
| Q1 25 | $406.5M | $530.9M | ||
| Q4 24 | $455.6M | $596.8M | ||
| Q3 24 | $451.5M | $681.4M | ||
| Q2 24 | $449.8M | $642.8M | ||
| Q1 24 | $452.0M | $618.5M |
| Q4 25 | $640.5M | — | ||
| Q3 25 | $646.3M | $946.5M | ||
| Q2 25 | $646.7M | $918.4M | ||
| Q1 25 | $646.1M | $945.9M | ||
| Q4 24 | $604.7M | $986.3M | ||
| Q3 24 | $601.5M | $1.1B | ||
| Q2 24 | $598.7M | $1.0B | ||
| Q1 24 | $571.7M | $986.6M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $33.8M |
| Free Cash FlowOCF − Capex | $9.8M | $32.6M |
| FCF MarginFCF / Revenue | 10.8% | 34.4% |
| Capex IntensityCapex / Revenue | 1.7% | 1.3% |
| Cash ConversionOCF / Net Profit | 2.11× | 1.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | $80.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | — | ||
| Q3 25 | $-8.9M | $33.8M | ||
| Q2 25 | $19.8M | $23.4M | ||
| Q1 25 | $-45.2M | $-19.6M | ||
| Q4 24 | $37.5M | $53.0M | ||
| Q3 24 | $10.4M | $19.5M | ||
| Q2 24 | $-15.3M | $10.7M | ||
| Q1 24 | $-21.5M | $-16.7M |
| Q4 25 | $9.8M | — | ||
| Q3 25 | $-9.8M | $32.6M | ||
| Q2 25 | $18.6M | $22.0M | ||
| Q1 25 | $-47.6M | $-23.6M | ||
| Q4 24 | $32.3M | $49.5M | ||
| Q3 24 | $8.9M | $18.1M | ||
| Q2 24 | $-18.9M | $9.9M | ||
| Q1 24 | $-25.0M | $-17.4M |
| Q4 25 | 10.8% | — | ||
| Q3 25 | -13.8% | 34.4% | ||
| Q2 25 | 17.3% | 23.0% | ||
| Q1 25 | -72.4% | -34.6% | ||
| Q4 24 | 34.0% | 68.8% | ||
| Q3 24 | 10.7% | 22.5% | ||
| Q2 24 | -24.6% | 13.5% | ||
| Q1 24 | -27.7% | -34.3% |
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.3% | 1.3% | ||
| Q2 25 | 1.1% | 1.5% | ||
| Q1 25 | 3.7% | 5.8% | ||
| Q4 24 | 5.6% | 4.8% | ||
| Q3 24 | 1.9% | 1.7% | ||
| Q2 24 | 4.7% | 1.1% | ||
| Q1 24 | 3.9% | 1.5% |
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | 2.31× | 1.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | 7.52× | ||
| Q3 24 | 20.52× | 1.11× | ||
| Q2 24 | — | 0.94× | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
